131I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past.
Fabozzi F, Villani MF, Del Bufalo F, Altini C, Cannatà V, Davide C, Pizzoferro M, Drago M, D'Antonio F, Triumbari EKA, Di Giannatale A, Vennarini S, Mastronuzzi A, De Ioris MA, Garganese MC.
Fabozzi F, et al. Among authors: d antonio f.
Crit Rev Oncol Hematol. 2024 Dec 26;207:104606. doi: 10.1016/j.critrevonc.2024.104606. Online ahead of print.
Crit Rev Oncol Hematol. 2024.
PMID: 39732302
Review.